Archived
Wednesday, December 09, 2015
Novian Health's Novilase® shows promising results for breast cancer patients
 »
Tuesday, November 17, 2015
ALPHAEON Pays $59 Million Cash For LensAR
 »
Thursday, August 20, 2015
Janus Biotherapeutics enters collaboration with Roche in autoimmune diseases
 »
Thursday, March 19, 2015

BioInvent Confirms Clinical Strategy for BI-505

 »
Wednesday, February 18, 2015
BioInvent Releases Updated Financial Statement for 1 January – 31 December 2014

 »
Tuesday, January 20, 2015
BioInvent’s BI-1206 antibody to enter collaborative Phase l/ll trial 
 »
Monday, December 01, 2014
Stratasys Printer Used to Perform Face Transplant 
 »
Tuesday, October 14, 2014

Lensar Partners With Precision Eye Services To Offer Full Service Mobile Laser Cataract Solution

 »
Thursday, September 11, 2014

BioInvent receives another milestone payment from Bayer in connection with start of a Phase I trial

 »
Monday, August 04, 2014
LensAR, Inc. Snags $8 Million For Laser Eye Surgery Systems
 »
Wednesday, May 21, 2014

Real Imaging Receives CE Mark for "Real Imager 8" - Breast Cancer Screening System

 »
Thursday, February 13, 2014
Painreform seeks new deal on pain management product
 »
Friday, February 07, 2014
Argos Therapeutics Prices Initial Public Offering
 »
Tuesday, November 12, 2013
LENSAR Initiates Clinical Study to Evaluate Lens Softening Effects of the LENSAR Laser System
 »
Monday, November 11, 2013
BioInvent granted US patent for the F.I.R.S.T.™ antibody screening technology
 »
Wednesday, October 02, 2013
Lensar Secures $87 Million in Financing to Support Market Expansion of its Laser Cataract Surgery System
 »
Monday, August 26, 2013
Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy
 »
Wednesday, April 03, 2013
Latest Clearance for LENSAR’s System Provides Cataract Surgeons with Enhanced Incision Functionality for All Cornea Cutting Procedures
 »
Tuesday, January 08, 2013
Analogic Signs Agreement to Acquire Ultrasonix Medical Corporation, Supplier of Advanced Ultrasound Solutions
 »
Monday, December 10, 2012
LENSAR Laser SystemTM Receives FDA Clearance for Corneal Incisions in Cataract Surgery
 »
Tuesday, April 24, 2012
Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
 »
Monday, March 12, 2012
LensAR Raises $24 Million in Private Financing to Support Commercial Launch of LensAR Laser System
 »
Saturday, February 04, 2012
Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis Immunotherapy, AGS-003, in Combination with Sunitinib for mRCC 
 »
Thursday, October 06, 2011
Topcon And LensAR Announce Equity Investment As Part Of Strategic Partnership
 »
Monday, October 03, 2011
Phosphagenics to Proceed with Twice Weekly Oxycodone Patch Development
 »
Tuesday, August 30, 2011
Extera Expands Its Orthopedic Pre-Launch Planning and Launch Management Services in Europe
 »
Friday, July 29, 2011
Extera Client Argos Therapeutics Files Registration Statement for Proposed Initial Public Offering
 »
Friday, June 10, 2011
Senior BioPharma Business Development Executives Join Extera Partners
 »
Thursday, May 19, 2011
Advantagene Announces SPA Agreement With FDA To Launch Phase 3 Trial For Novel Vaccine Aimed At Preventing Prostate Cancer Recurrence
 »
Wednesday, May 11, 2011
Extera Client Nexstim Attracts Additional Equity Financing - Over EUR 13 Million Now Raised in Latest Round
 »
Monday, March 28, 2011
Extera Europe and Notified Body LNE/G-MD to Present Free Webinar, Accessing the European Medical Device Market: Smart Approaches to CE Marking and Effective Commercialization
 »
Wednesday, December 22, 2010
XCounter AB Announces Its Proposal to Raise £1.936 Million to Provide Funding for the Group's Organic Growth Strategy and Business
 »
Wednesday, December 08, 2010
Extera's General Partner a Panelist at MIT Enterprise Forum of Cambridge Event: The Covidien Story: Commitment to Innovation, New Ideas and Technology
 »
Thursday, October 21, 2010
Cephalon Exercises Its Option to Acquire BioAssets Development Corporation 
 »
Tuesday, October 19, 2010
Senior Executive Jean-Pierre Capdevielle Joins Extera Partners to Assist Non-European Medtech Companies with Expansion into Europe
 »
Wednesday, September 08, 2010
LensAR Appoints Extera General Partner Chief Commercial Officer 
 »
Friday, July 30, 2010
LensAR Raises $7M in New Financing and Appoints Extera's General Partner to Board of Directors
 »
Tuesday, July 20, 2010
Extera Partners Adds Steven Berntiz as a General Partner
 »
Sunday, June 20, 2010
Extera Facilitates National Distribution Agreements  
 »
Wednesday, May 26, 2010
Exalenz Builds US Sales Infrastructure With Extera's Support
 »
Thursday, December 10, 2009
FDA Clears Nexstim's Navigated Brain Stimulation 
 »
Wednesday, December 02, 2009
Pharma Voice: "REFORM, CONSOLIDATION AND GOOD CITIZENRY", Interview with Joseph Baron, Extera Partners 
 »
Tuesday, November 17, 2009
Genetic Engineering & Biotechnology News Article: "How Biotech Unions Could Save Companies and Revitalize Pipelines" By Joseph Baron, Extera Partners
 »
Tuesday, November 10, 2009
Lothar Koob Joins EDGE Medical Devices Board of Directors 
 »
Monday, October 26, 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
 »
Tuesday, July 01, 2008
Extera is Supporting Strategy and Commercialization Efforts of a Leading Israeli Life Science Company 
 »
Wednesday, April 16, 2008
Extera Partners to moderate a panel at the MIT Sloan BioInnovations Conference in Cambridge Massachusetts 
 »
Saturday, March 01, 2008

Dr. Robert Parnell Joins Extera Partners to Expand Its Diagnostics Advisory Capabilities 

 »
Monday, October 01, 2007
Innovations in Breast Imaging: (Highlighting Extera's work with Karmanos Cancer Institute)
 »
Monday, August 07, 2006
Novelos Therapeutics Inc. (OTCBB: NVLT), obtains FDA Fast Track Designation
 »
Thursday, August 04, 2005
Extera Client, Alchemia Limited ((ASX: ACL), is named Queensland's "Smartest" company
 »